Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision’s highlights from Q4 2024 along with the financials for the quarter and full year. The Webcast is available on ContextVision’s website following the link below: For more details, contact ContextVision’s…
Q4 highlights Attended the RSNA Conference in Chicago and launched two products. Ongoing discussions about collaborations with key customers, including tier 1 OEMs. Strong interest in the industry regarding quantitative imaging – reinforcing our strategy. Continued progress within Data Quality…
ContextVision, a global market leader in medical imaging solutions, has partnered with the University of Washington, a top ten university that is globally recognized for its research and clinical excellence. The university’s healthcare system, UW Medicine, brings significant clinical expertise…
Stockholm, Dec 18, 2024 A correction is made to the press release published today, December 18, 2024, at 08.10 AM, regarding the number of shares resolved to be bought back by the company. A number of 35,722 shares were not…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN UNITED STATES, CANADA, AUSTRALIA, JAPAN OR ANY JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES. Stockholm, Dec 18, 2024 Reference is made…
Martin Hedlund, member of the Board of ContextVision has purchased shares in ContextVision. With reference to Section 4-2 of the Norwegian Securities Trading Act (“STA”), kindly note the following primary insider share transactions: Name of listed entity: ContextVision AB ISIN…
With reference to Section 4-2 of the Norwegian Securities Trading Act (“STA”), kindly note the following primary insider share transactions: Name of listed entity: ContextVision AB ISIN number: SE0014731154 Stock ticker: CONTX Name of primary insider: Olof Sandén Relation to…
At the Extraordinary General Meeting of ContextVision AB (publ) held on November 20, 2024, the following decisions were made: Authorization for the Board of Directors to resolve on the acquisition of the company’s own shares The General Meeting resolved in…
ContextVision Q3 report Q&A interview: Record topline growth and strong margins With a record revenue and a solid EBITDA margin of 44% in Q3 as well as the first nine months, the company reaffirms its foundation for growth. The strong…
Q3 Highlights Continuing integration with newly signed customers in Asia and North America. Close collaboration with the market to receive feedback from customers to strategically develop and enhance our products. Internal reorganization to strenghen our teams and become more effective…